ESC 365 - Discussion and conclusion

Open Access

Discussion and conclusion

Session: Protecting the heart during cancer therapy - How to manage the risk of sudden cardiac death?

Topic: Heart Failure

Sponsored by Zoll

Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

3 more presentations in this session

Welcome and introduction

Speaker: Professor I. Goldenberg (Rochester, US)

How to manage arrhythmogenic cardiotoxicity and the risk of life-threatening ventricular arrhythmias and sudden cardiac death during cancer therapy?

Speaker: Associate Professor D. Farmakis (Athens, GR)

Recovery of chemotherapy-related acute heart failure - what roles play current HF medication and the Wearable Cardioverter Defibrillator? - interactive case discussions

Speaker: Doctor M. Canale (Lido Di Camaiore, IT)

Access the full session

Protecting the heart during cancer therapy - How to manage the risk of sudden cardiac death?

Speakers: Professor I. Goldenberg, Associate Professor D. Farmakis, Doctor M. Canale

About the event

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources